United States Nuclear Imaging Equipment Market Outlook to 2020

Publisher Name :
Date: 7-Mar-2014
No. of pages: 85

GlobalData’s new report, “United States Nuclear Imaging Equipment Market Outlook to 2020″, provides key market data on the United States Nuclear Imaging Equipment market. The report provides value, in millions of US dollars, and volume (in units) and average price data (in US dollars), within market categories Positron Emission Tomography Systems (PET Systems and PET/CT Systems) and Single Photon Emission Computed Tomography Systems (SPECT Systems and SPECT/CT Systems).

The report also provides company shares and distribution shares data for each of these market categories, and global corporate-level profiles of the key market participants, pipeline products, and news and deals related to the Nuclear Imaging Equipment market wherever available.

The data in the report is derived from dynamic market forecast models. GlobalData uses capital equipment-based models to estimate and forecast the market size. The objective is to provide information that represents the most up-to-date data of the industry possible.

Capital equipment-based forecasting models are done based on the installed base, replacements and new sales of a specific device/equipment in healthcare facilities such as hospitals, clinics and diagnostic centers. Data for average number of units per facility is used to arrive at the installed base of the capital equipment. Sales for a particular year are arrived at by calculating the replacement units and new units (additional and first-time purchases).

Extensive interviews are conducted with key opinion leaders (KOLs), physicians and industry experts to validate the market size, company share and distribution share data and analysis.

Scope

  • Market size for Nuclear Imaging Equipment market categories Positron Emission Tomography Systems (PET Systems and PET/CT Systems) and Single Photon Emission Computed Tomography Systems (SPECT Systems and SPECT/CT Systems).
  • Annualized market revenues (USD million), volume (units) and average selling price ($) data for each of the market categories. Data is provided from 2005 to 2012 and forecast to 2020.
  • 2012 company shares and distribution shares data for each of the market categories.
  • Global corporate-level profiles of key companies operating within the United States Nuclear Imaging Equipment market.
  • Key players covered include GE Healthcare, Philips Healthcare and Siemens Healthcare.

Reasons to buy

  • Develop business strategies by identifying the key market segments poised for strong growth in the future.
  • Develop market-entry and market expansion strategies.
  • Design competition strategies by identifying who-stands-where in the market.
  • Develop investment strategies by identifying the key market segments expected to register strong growth in the near future.
  • What are the key distribution channels and what’s the most preferred mode of product distribution Identify, understand and capitalize.

United States Nuclear Imaging Equipment Market Outlook to 2020

Table of Contents

1 Table of Contents 2
1.1 List of Tables 5
1.2 List of Figures 6

2 Introduction 7
2.1 What Is This Report About? 7
2.2 Nuclear Imaging Equipment Market Segmentation 7
2.3 Definitions of Markets Covered in the Report 8

3 Nuclear Imaging Equipment Market, United States 10
3.1 Nuclear Imaging Equipment Market, United States, Revenue ($m), 2005-2012 10
3.2 Nuclear Imaging Equipment Market, United States, Revenue ($m), 2012-2020 12
3.2.1 Positron Emission Tomography Systems Market, United States, Revenue ($m), by Segment, 2005-2012 14
3.2.2 Single Photon Emission Computed Tomography Systems Market, United States, Revenue ($m), by Segment, 2005-2012 16
3.2.3 Positron Emission Tomography Systems Market, United States, Revenue ($m), by Segment, 2012-2020 18
3.2.4 Single Photon Emission Computed Tomography Systems Market, United States, Revenue ($m), by Segment, 2012-2020 20
3.3 Nuclear Imaging Equipment Market, United States, Volume (Units), 2005-2012 22
3.4 Nuclear Imaging Equipment Market, United States, Volume (Units), 2012-2020 24
3.4.1 Positron Emission Tomography Systems Market, United States, Volume (Units), by Segment, 2005-2012 26
3.4.2 Single Photon Emission Computed Tomography Systems Market, United States, Volume (Units), by Segment, 2005-2012 28
3.4.3 Positron Emission Tomography Systems Market, United States, Volume (Units), by Segment, 2012-2020 30
3.4.4 Single Photon Emission Computed Tomography Systems Market, United States, Volume (Units), by Segment, 2012-2020 32
3.5 Nuclear Imaging Equipment Market, United States, Average Price ($), 2005-2020 34
3.6 Nuclear Imaging Equipment Market, United States, Distribution Share by Revenue ($m), 2011-2012 36
3.7 Nuclear Imaging Equipment Market, United States, Company Share by Revenue ($m), 2011-2012 37

4 Overview of Key Companies in United States, Nuclear Imaging Equipment Market 39
4.1 Philips Healthcare 39
4.1.1 Company Overview 39
4.2 GE Healthcare 39
4.2.1 Company Overview 39
4.3 Siemens Healthcare 40
4.3.1 Company Overview 40

5 Nuclear Imaging Equipment Market Pipeline Products 41

6 Financial Deals Landscape 42
6.1 Acquisition 42
6.1.1 Biosensors International Completes Acquisition Of Spectrum Dynamics For US$72.5 Million 42
6.1.2 BC Technical Acquires Nuclear Cardiology Systems, Provider Of Nuclear Medical Services 44
6.1.3 BC Technical Completes Acquisition Of Genesis Medical Imaging 45
6.1.4 BC Technical Acquires Xpert, Molecular Imaging Service Company 46
6.2 Asset Transactions 47
6.2.1 Novadaq Technologies Acquires Surgical Imaging Technology Assets From Digirad For US$3 Million 47
6.3 Equity Offerings 49
6.3.1 LipoScience Completes IPO For US$52 Million 49
6.4 Partnerships 51
6.4.1 Positron And Biologics Modular Enter Into Co-Marketing Agreement For PosiRx System 51

7 Recent Developments 52
7.1 Corporate Communications 52
7.1.1 Feb 25, 2014: Molecular Imaging Services Appoints Dr. Gary Heller as Chief Medical Officer 52
7.1.2 Jan 22, 2014: LipoScience Announces Appointment of Howard Doran as President and Chief Executive Officer 52
7.1.3 Sep 06, 2013: LipoScience Announces Appointment Of William Cromwell, M.D., As Chief Medical Officer 53
7.1.4 Aug 09, 2013: LipoScience Announces Appointment Of Vice President, General Counsel And Corporate Secretary 54
7.1.5 Aug 08, 2013: LipoScience Announces Two New Members of Board of Directors 54
7.1.6 Aug 02, 2013: LipoScience Appoints Robert Greczyn Interim President and Chief Executive Officer 55
7.1.7 Jul 11, 2013: Lantheus Medical Imaging Announces Chief Financial Officer Transition 55
7.1.8 Jul 01, 2013: Matthew G. Molchan Assumes the CEO Role at Digirad 56
7.1.9 Mar 06, 2013: Lantheus Medical Imaging Appoints Cesare Orlandi As CMO 56
7.2 Financial Announcements 57
7.2.1 Feb 26, 2014: Digirad Reports Fourth Quarter and Year-End Financial Results 57
7.2.2 Feb 03, 2014: Digirad Announces Quarterly Dividend of $0.05 Per Share 58
7.2.3 Jan 24, 2014: Gagnon Cardiovascular Institute At Morristown Medical Center Implants Newly Approved Device To Replace Failing Aortic Heart Valves 59
7.2.4 Nov 21, 2013: LipoScience to Discuss 2014 Guidance on Fourth Quarter 2013 Financial Results Conference Call 61
7.2.5 Nov 06, 2013: Lantheus Medical Imaging to Host Third Quarter 2013 Conference Call on November 13, 2013 at 3:00 p.m. Eastern Time 61
7.2.6 Nov 05, 2013: LipoScience Reports Third Quarter 2013 Financial Results 61
7.2.7 Oct 22, 2013: LipoScience to Release Third Quarter Fiscal Year 2013 Financial Results 63
7.2.8 Oct 15, 2013: Digirad to Release 2013 Third Quarter and Nine-Month Financial Results on November 1, 2013 63
7.2.9 Aug 06, 2013: LipoScience Reports Second Quarter 2013 Financial Results 63
7.2.10 Aug 01, 2013: Lantheus Medical Imaging to Host Second Quarter 2013 Conference Call on August 8, 2013 at 4:00 p.m. Eastern Time 65
7.2.11 Aug 01, 2013: Digirad Corporation Reports Second Quarter and Six-Month Financial Results 65
7.2.12 Jul 23, 2013: LipoScience to Release Second Quarter Fiscal Year 2013 Financial Results 67
7.2.13 Jul 18, 2013: Digirad Corporation to Release 2013 Second Quarter and Six-Month Financial Results on August 1, 2013 67
7.2.14 May 09, 2013: LipoScience Reports Revenue Of $13.6m In Q1 2013 67
7.2.15 May 06, 2013: Digirad Corporation Reports First Quarter Financial Results 69
7.2.16 Mar 27, 2013: LipoScience Reports Revenue Of $54.8m In 2012 70
7.3 Government and Public Interest 72
7.3.1 Nov 27, 2013: LipoScience to present at 25th Annual Piper Jaffray Healthcare Conference 72
7.3.2 Nov 27, 2013: LipoScience to Present at 25th Annual Piper Jaffray Healthcare Conference 73
7.3.3 Nov 14, 2013: Digirad to present at the 6th annual LD MICRO conference 73
7.3.4 Sep 10, 2013: Lantheus Medical Imaging to Present at Imperial Capital Global Opportunities Conference on September 19, 2013 73
7.3.5 Aug 02, 2013: Digirad to Present at the 2013 Southern California Investor Conference 73
7.4 Other Significant Developments 74
7.4.1 Jan 22, 2014: Nanotherapeutics selects GE Healthcare Life Sciences technologies for Advanced Development and Manufacturing Center 74
7.4.2 Nov 13, 2013: NGAGE Announces Representation Agreement with SIEMENS Healthcare 74
7.4.3 Sep 09, 2013: Digirad Signs Agreement to Outsource Imaging Equipment Manufacturing 75
7.4.4 Mar 19, 2013: Lantheus Medical Imaging Announces Molybdenum-99 Supply Contract With IRE 75
7.5 Strategy And Business Planning 76
7.5.1 Mar 21, 2013: Lantheus Announces Corporate Plans 76

8 Appendix 77
8.1 Research Methodology 78
8.1.1 Coverage 78
8.1.2 Secondary Research 78
7.1.3 Primary Research 79
8.1.4 Market Modeling and Forecasting 80
8.1.5 Company Share Analysis 83
8.1.6 Distribution Share Analysis 84
8.2 Expert Panel 85
8.3 GlobalData Consulting 85
8.4 Contact Us 85
8.5 Disclaimer 85

List of Tables

Table 1: Nuclear Imaging Equipment Market, United States, Revenue ($m), USD Constant, Historic, 2005-2012 11
Table 2: Nuclear Imaging Equipment Market, United States, Revenue ($m), USD Constant, Forecast, 2012-2020 13
Table 3: Positron Emission Tomography Systems Market, United States, Revenue ($m), USD Constant, Historic, 2005-2012 15
Table 4: Single Photon Emission Computed Tomography Systems Market, United States, Revenue ($m), USD Constant, Historic, 2005-2012 17
Table 5: Positron Emission Tomography Systems Market, United States, Revenue ($m), USD Constant, Forecast, 2012-2020 19
Table 6: Single Photon Emission Computed Tomography Systems Market, United States, Revenue ($m), USD Constant, Forecast, 2012-2020 21
Table 7: Nuclear Imaging Equipment Market, United States, Volume (Units), Historic, 2005-2012 23
Table 8: Nuclear Imaging Equipment Market, United States, Volume (Units), Forecast, 2012-2020 25
Table 9: Positron Emission Tomography Systems Market, United States, Volume (Units), Historic, 2005-2012 27
Table 10: Single Photon Emission Computed Tomography Systems Market, United States, Volume (Units), Historic, 2005-2012 29
Table 11: Positron Emission Tomography Systems Market, United States, Volume (Units), Forecast, 2012-2020 31
Table 12: Single Photon Emission Computed Tomography Systems Market, United States, Volume (Units), Forecast, 2012-2020 33
Table 13: Nuclear Imaging Equipment Market, United States, Average Price ($), Historic, 2005-2012 34
Table 14: Nuclear Imaging Equipment Market, United States, Average Price ($), Forecast, 2012-2020 35
Table 15: Nuclear Imaging Equipment Market, United States, Distribution Share by Revenue ($m), USD Constant, 2011-2012 36
Table 16: Nuclear Imaging Equipment Market, United States, Company Share by Revenue ($m), USD Constant, 2011-2012 38
Table 17: Nuclear Imaging Equipment Market Pipeline Products 41
Table 18: Biosensors International Completes Acquisition Of Spectrum Dynamics For US$72.5 Million 42
Table 19: BC Technical Acquires Nuclear Cardiology Systems, Provider Of Nuclear Medical Services 44
Table 20: BC Technical Completes Acquisition Of Genesis Medical Imaging 45
Table 21: BC Technical Acquires Xpert, Molecular Imaging Service Company 46
Table 22: Novadaq Technologies Acquires Surgical Imaging Technology Assets From Digirad For US$3 Million 47
Table 23: LipoScience Completes IPO For US$52 Million 49
Table 24: Positron And Biologics Modular Enter Into Co-Marketing Agreement For PosiRx System 51
Table 25: Total Number of Primary Research Participants, Diagnostic Imaging Equipment Market, by Country 80

List of Figures

Figure 1: Nuclear Imaging Equipment Market, United States, Revenue ($m), USD Constant, Historic, 2005-2012 10
Figure 2: Nuclear Imaging Equipment Market, United States, Revenue ($m), USD Constant, Forecast, 2012-2020 12
Figure 3: Positron Emission Tomography Systems Market, United States, Revenue ($m), USD Constant, Historic, 2005-2012 14
Figure 4: Single Photon Emission Computed Tomography Systems Market, United States, Revenue ($m), USD Constant, Historic, 2005-2012 16
Figure 5: Positron Emission Tomography Systems Market, United States, Revenue ($m), USD Constant, Forecast, 2012-2020 18
Figure 6: Single Photon Emission Computed Tomography Systems Market, United States, Revenue ($m), USD Constant, Forecast, 2012-2020 20
Figure 7: Nuclear Imaging Equipment Market, United States, Volume (Units), Historic, 2005-2012 22
Figure 8: Nuclear Imaging Equipment Market, United States, Volume (Units), Forecast, 2012-2020 24
Figure 9: Positron Emission Tomography Systems Market, United States, Volume (Units), Historic, 2005-2012 26
Figure 10: Single Photon Emission Computed Tomography Systems Market, United States, Volume (Units), Historic, 2005-2012 28
Figure 11: Positron Emission Tomography Systems Market, United States, Volume (Units), Forecast, 2012-2020 30
Figure 12: Single Photon Emission Computed Tomography Systems Market, United States, Volume (Units), Forecast, 2012-2020 32
Figure 13: Nuclear Imaging Equipment Market, United States, Company Share (%), 2012 37
Figure 14: GlobalData Epidemiology-Based Forecasting Model 82
Figure 15: GlobalData Capital Equipment-Based Forecasting Model 83
Figure 16: Primary Interviews by Participant Type (%) 84

  • Challenges in the Tourism Industry in Thailand
    Thailand has always been a popular tourist destination and tourism provides a major boost to the country’s economy. Bangkok, Hua Hin, Krabi, Samui, Phuket and Cha Am are some of the most attractive tourist destinations in the country. In 2012, Thailand had a very high number of arrivals. Even the number of Thai citizens who [...]
  • Future of the US Consumer Electronics Market
    The market for consumer electronics has been growing steadily. Some of the factors that are contributing to the growth in the market are technological advancement, rise in disposable income and increasing demand for new products. During 2012, consumer electronics market in the US demonstrated positive expansion, although the growth rate slowed down considerably following the [...]
  • Overview of the Global Retail Market
    The global retail industry continued to grow despite the difficult economic conditions in the world. In the fiscal year of 2011, sales-weighted, currency-adjusted revenue rose by 5.1% to $4.271 trillion for the world’s top 250 retailers. According to GRDI (Global Retail Development Index), in 2013 Brazil occupied the top spot in retail development. Chile and [...]
  • Bright Future Predicted for the Tourism Industry in Singapore
    Travel and tourism industry in Singapore has been growing at a steady rate and is considered to be a major contributor to the economic growth of the country. In 2012, Singapore’s IVA (International Visitors Arrivals) reached a record high of 14.5 million, with a growth rate of 10.1% year-on-year. In recent years, inbound travel to [...]
  • Potential of Staffing Market in United States
    The staffing industry places individuals into contract, temporary and permanent positions in firms around the world. Major staffing markets include France, Spain, Italy and Japan as well as many emerging markets. Temporary staffing around the world has been growing, but in US temporary market has been flat since 2006. The majority of staffing revenue majorly [...]
  • Graft-Versus-Host Disease (GVHD) Treatment Market worth $407 million by 2018
  • The graft-versus-host disease (GVHD) treatment market value will increase from $297 million in 2013 to $407 million by 2018, at a Compound Annual Growth Rate (CAGR) of 6.59%, according to research and consulting firm GlobalData. The company’s latest report* states …

  • Poland Pharmaceutical Industry Growing at 8.3% CAGR to 2020
  • Factors such as the growing elderly population, increasing availability of affordable medicines, and transparent regulatory guidelines will provide the necessary impetus for the growth of the Polish pharmaceutical market, but a decrease in mark-up prices and the country’s stringent drug …

  • Asia-Pacific, Led by China, Drive the Global Methanol Industry
  • China is driving the global methanol industry, with tremendous demand from both its energy and petrochemicals sectors. It accounts for 87.9% of Asia-Pacific’s (APAC) methanol capacity, and 51.9% of the global methanol capacity. Despite a large planned capacity increase in …

  • Diagnostic X-ray Imaging Market worth $4.0 billion by 2020
  • GlobalData estimates that the global diagnostic X-ray imaging market, worth $2.4 billion in 2012, will reach almost $4.0 billion by 2020, increasing at a Compound Annual Growth Rate (CAGR) of 6.7% during the forecast period. Many players are active in …

  • Graft-Versus-Host Disease Market Forecast to 2023
  • Graft-versus-host disease (GVHD) is a common complication of allogeneic hematopoietic stem cell transplantation (HSCT) that occurs when the donated (graft) cells are rejected and attack the host’s cells as foreign. GVHD can progress from mild to severe forms as either …

  • Future Horizons and Growth Strategies in the US Hospital Microbiology Testing Market 2014: Supplier Shares and Country Forecasts
    Published: 28-Aug-2014        Price: US $6800 Onwards        Pages: 997
    This new report from Venture Planning Group contains 997 pages, 87 tables, and presents a comprehensive opportunities in the US hospital microbiology testing market, including: Major issues pertaining to the US hospital laboratory practice, as well as key economic, regulatory, demographic, social and technological trends with significant market impact during the next ten years. Current scientific views on the definition, epidemiology, and etiology of major infectious diseases and microorga......
  • Future Horizons and Growth Strategies in the Spanish Diagnostics Market 2014: Supplier Shares and Country Forecasts
    Published: 28-Aug-2014        Price: US $4850 Onwards        Pages: 56
    This new report from Venture Planning Group provides an overview of the Spanish diagnostic testing market, including sales and market shares of leading reagent and instrument suppliers, as well as test volume and sales forecasts for the following market segments: Blood Banking Cancer Chemistry Coagulation Drugs of Abuse Endocrine Hematology and Flow Cytometry Immunoprotein Infectious Diseases Molecular Diagnostics TDM ......
  • Future Horizons and Growth Strategies in the German Hospital Hemostasis Diagnostic Testing Market 2014: Supplier Shares and Country Forecasts
    Published: 28-Aug-2014        Price: US $3900 Onwards        Pages: 394
    This new report from Venture Planning Group contains 394 pages, 28 tables, and presents a comprehensive analysis of the German hospital hemostasis diagnostic testing market, including: Major issues pertaining to the German coagulation laboratory practice, as well as key economic, regulatory, demographic, social and technological trends with significant market impact during the next ten years. Volume and sales forecasts for 40 coagulation procedures performed in German hospitals, including ......
  • Future Horizons and Growth Strategies in the US Transfusion Diagnostic Testing Market 2014: Supplier Shares and Country Forecasts
    Published: 28-Aug-2014        Price: US $9700 Onwards        Pages: 460
    This comprehensive report is designed to help current suppliers and potential market entrants identify and evaluate emerging opportunities in the US transfusion diagnostic market during the next five years, and assist industry executives in developing effective business, new product development and marketing strategies. The report explores future marketing and technological trends in US; provides test volume and sales forecasts by market segment/test location; compares features of major autom......
  • Future Horizons and Growth Strategies in the Japanese Microbiology Testing Market 2014: Supplier Shares and Country Forecasts
    Published: 28-Aug-2014        Price: US $8800 Onwards        Pages: 976
    "2014 Strategies for the Japanese Microbiology Testing Market" is a new strategic analysis of major business opportunities emerging in the infectious disease testing market during the next five years. The report examines key Japanese market trends; reviews current and emerging assays; analyzes potential applications of innovative diagnostic technologies; forecasts volume and sales for over 100 infectious disease tests by assay, and market segment; provides test volume estimates by method (molecu......
  • Future Horizons and Growth Strategies in the German Hospital Tumor Marker Testing Market 2014: Supplier Shares and Country Forecasts
    Published: 28-Aug-2014        Price: US $3850 Onwards        Pages: 530
    This new report from Venture Planning Group contains 530 pages, 40 tables, and presents a comprehensive analysis of the German hospital tumor marker testing market, including: Major issues pertaining to the German hospital laboratory practice, as well as key economic, regulatory, demographic, social and technological trends with significant market impact during the next five years. Mortality statistics and scientific views on the etiology of major types of cancer, e.g., lung, colorectal, b......
  • Future Horizons and Growth Strategies in the Global Hemostasis Diagnostic Testing Market 2014: Supplier Shares and Country Forecasts
    Published: 28-Aug-2014        Price: US $32500 Onwards        Pages: 650
    This comprehensive seven-country report contains 650 pages, 150 tables, and is designed to help current suppliers and potential market entrants identify and evaluate business opportunities emerging in the global coagulation testing market during the next five years. The report explores business and technological trends in the US, Europe (France, Germany, Italy, Spain, UK) and Japan; provides estimates of the test volume, as well as sales and market shares of leading competitors; compares feat......
  • Future Horizons and Growth Strategies in the Global Nucleic Acid Testing Market 2014: Supplier Shares and Country Forecasts
    Published: 28-Aug-2014        Price: US $32200 Onwards        Pages: 1050
    Highlights Business and technological trends in seven major markets Fiveand ten-year test volume and sales forecasts Market shares of leading competitors Feature comparison of major analyzers Profiles of market players and start-up firms developing innovative technologies and products Specific product and business opportunities for instrument and consumable suppliers. Rationale The NAT market is unquestionably the most rapidly growing segment of the in vitro diagnostics indus......
  • Future Horizons and Growth Strategies in the UK Diagnostics Market 2014: Supplier Shares and Country Forecasts
    Published: 28-Aug-2014        Price: US $4850 Onwards        Pages: 64
    This new report from Venture Planning Group provides an overview of the UK diagnostic testing market, including sales and market shares of leading reagent and instrument suppliers, as well as test volume and sales forecasts for the following market segments: Blood Banking Cancer Chemistry Coagulation Drugs of Abuse Endocrine Hematology and Flow Cytometry Immunoprotein Infectious Diseases Molecular Diagnostics TDM ......
  • SERVICES
    Value for Money
    We believe in "optimum utilization of available budget and resources". While servicing our clients' (your) market research requirements, we keep the same approach in focus to help you get the best value for your $$s.
    Ever Growing Inventory
    Ranging from the smallest feasible / required data (datasheets, data facts, SWOT analysis, company profiles, etc) to full research reports that help you make decisions, our inventory is updated almost on a daily basis with the latest industry reports from domain experts that track more than 5000 niche sectors.
    One Stop Solution
    Need a custom research report on medical devices market? Require all available business intelligence on 3D printing industry? Exploring F&B sector of a particular country/region? RnRMarketResearch.com is your one-stop-solution to all market intelligence needs. We not only offer custom research and consulting services, we also "bundle" reports to meet your needs and help you fetch the data analysis you require for your business.
    Dedicated Client Engagement
    Not limited to only "finding" relevant reports for you, our client engagement team dedicates its efforts to understand your "business need" and accordingly maps available research data to help you move forward. Call "your" client engagement executive any time of your day and get your questions answered in order to make the correct business decision.
    Saving Time and Efforts
    Simply share your research requirement details with us and let us do all the hard work to find required intelligence for you. When you add up our "one stop solution" and "dedicated client engagement" services mentioned above, you obviously know the time and effort saving you do by working with us.
    Payment Flexibility
    Working with Fortune 500 organizations, we understand the importance of being flexible for payments. Share your payment terms with us and we will surely match up to them to ensure you get access to required business intelligence data without having to wait for the payment to be done.
    Post-Purchase Research Support
    Have questions after reading a report / datasheet bought through us? Not sure about the methodology used for data available in the research? Talk to us / Share your questions with us and if required, we will connect you with the analyst(s)/author(s) of the report(s) and ensure you get satisfactory answers for the same. Need more data / analysis / report(s) on the topic of your research/project? The RnRMarketResearch.com team is here for you 24X7 to support you with your post-purchase requirements. Subscription Offers & Packages (Get in touch with us for more details - sales@rnrmarketresearch.com / +1 888 391 5441 )
    • Ad Hoc
    • Pay - as - you - go / Bucket Subscriptions
    • Fixed Cost for #of reports
    • Customize / Personalize as per your needs